Literature DB >> 11828372

Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis.

Britta Siegmund1, Kelly C Lear-Kaul, Raffaella Faggioni, Giamila Fantuzzi.   

Abstract

Leptin-deficient ob/ob mice are protected from Con A-induced hepatitis. However, it is unclear whether leptin deficiency or obesity itself is responsible for this protection. To address this question, wild-type (WT) obese mice with high serum leptin levels were generated by injection of gold thioglucose (WT GTG). Both Con A-injected WT and WT GTG mice developed hepatitis, whereas no hepatic damage was observed in ob/ob mice. Moreover, TNF-alpha and IFN-gamma levels as well as expression of the activation marker CD69 were elevated in liver mononuclear cells of WT and WT GTG mice, but not in ob/ob mice following administration of Con A. The liver of WT and WT GTG mice had the same percentage of NK T cells, a lymphocyte population involved in Con A-induced hepatitis. This population decreased equally in both WT and WT GTG mice after Con A injection. In contrast, the liver of ob/ob mice contained 50% less NK T cells compared to WT and WT GTG mice. Furthermore, no decrease in NK T cells was observed in Con A-injected ob/ob mice. We conclude that leptin-deficiency, not obesity, is responsible for protection from Con A-induced hepatitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828372     DOI: 10.1002/1521-4141(200202)32:2<552::AID-IMMU552>3.0.CO;2-H

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

Review 1.  Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span.

Authors:  Vishwa Deep Dixit
Journal:  J Leukoc Biol       Date:  2008-06-25       Impact factor: 4.962

2.  Defining the role of T cell-derived leptin in the modulation of hepatic or intestinal inflammation in mice.

Authors:  G Fantuzzi; J A Sennello; A Batra; I Fedke; H A Lehr; M Zeitz; B Siegmund
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. [corrected].

Authors:  P M M Moraes-Vieira; E J Bassi; R A Larocca; A Castoldi; M Burghos; A P Lepique; F J Quintana; R C Araujo; A S Basso; T B Strom; N O S Câmara
Journal:  Am J Transplant       Date:  2012-09-27       Impact factor: 8.086

Review 4.  IL-17 in obesity and adipogenesis.

Authors:  Mushtaq Ahmed; Sarah L Gaffen
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-16       Impact factor: 7.638

5.  Leptin and Inflammation.

Authors:  Noriko Iikuni; Queenie Lai Kwan Lam; Liwei Lu; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Immunol Rev       Date:  2008-05-01

6.  Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats.

Authors:  Christelle Sachot; Stephen Poole; Giamal N Luheshi
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

7.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.

Authors:  Maria Pini; Melissa E Gove; Joseph A Sennello; Jantine W P M van Baal; Lawrence Chan; Giamila Fantuzzi
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 8.  Three questions about leptin and immunity.

Authors:  Giamila Fantuzzi
Journal:  Brain Behav Immun       Date:  2008-10-25       Impact factor: 7.217

9.  Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice.

Authors:  Melissa E Gove; Davina H Rhodes; Maria Pini; Jantine W van Baal; Joseph A Sennello; Raja Fayad; Robert J Cabay; Martin G Myers; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2008-12-03       Impact factor: 4.962

10.  Leptin deficiency in vivo enhances the ability of splenic dendritic cells to activate T cells.

Authors:  Oscar Ramirez; Kristine M Garza
Journal:  Int Immunol       Date:  2014-06-25       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.